Cargando…

Once-daily 5 mg tadalafil oral treatment for patients with chronic prostatitis/chronic pelvic pain syndrome

BACKGROUND: Chronic prostatitis/chronic pelvic pain syndrome (IIIB CP/CPPS) is a condition of unclear aetiology. Many approaches have been used without satisfactory results. The aim of this study is to evaluate the efficacy of once-daily 5 mg tadalafil in pain control and improving quality of life i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benelli, Andrea, Mariani, Simone, Varca, Virginia, Gregori, Andrea, Barrese, Franco, Cappa, Manilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295787/ https://www.ncbi.nlm.nih.gov/pubmed/30574197 http://dx.doi.org/10.1177/1756287218808677

Ejemplares similares

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy
por: Washington, Samuel L, et al.
Publicado: (2010)

Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives
por: Costa, Pierre, et al.
Publicado: (2009)

The Efficacy and Safety of Tadalafil 5 mg Once Daily in Korean Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: An Integrated Analysis
por: Lee, Sung Won, et al.
Publicado: (2014)

Efficacy and Safety of Tadalafil 5 mg Administered Once Daily in Korean Men with Erectile Dysfunction: A Prospective, Multicenter Study
por: Kang, Dong Hyuk, et al.
Publicado: (2010)

Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities
por: Hatzichristou, Dimitrios, et al.
Publicado: (2015)

Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis
por: Cui, Jianwei, et al.
Publicado: (2021)

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
por: Falk, Jeremy A, et al.
Publicado: (2010)

Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily
por: Iacono, Fabrizio, et al.
Publicado: (2012)

The role of MRI/TRUS fusion biopsy in the diagnosis of clinically significant prostate cancer
por: Benelli, Andrea, et al.
Publicado: (2020)

Serum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients With Erectile Dysfunction and Diabetes
por: Lee, Jung Woo, et al.
Publicado: (2013)

Role of application of tadalafil 5 mg once-daily (≥6 months) in men with erectile dysfunction from six randomized controlled trials
por: Ma, Jiajia, et al.
Publicado: (2020)

Efficacy of Continuous Dosing of Tadalafil Once Daily vs Tadalafil On Demand in Clinical Subgroups of Men With Erectile Dysfunction: A Descriptive Comparison Using the Integrated Tadalafil Databases
por: Brock, Gerald, et al.
Publicado: (2016)

AB083. Does concomitant testosterone replacement improve the response of tadalafil 5 mg once daily in men with lower urinary tract symptoms?
por: Park, Nam Cheol, et al.
Publicado: (2016)

Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia
por: Zarifpour, Mona, et al.
Publicado: (2015)

AB167. Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction
por: Cui, H, et al.
Publicado: (2014)

Tadalafil once daily and intralesional verapamil injection: A new therapeutic direction in Peyronie's disease
por: Dell’Atti, Lucio
Publicado: (2015)

Daily tadalafil for the chronic phase of stuttering priapism: a case report
por: Massenio, Paolo, et al.
Publicado: (2018)

An observational study to monitor the efficacy and tolerability of levofloxacin 500 mg once daily for treatment of chronic bacterial prostatitis in Saudi Arabia
por: El Meliegy, Amr Ismail, et al.
Publicado: (2015)

The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up
por: Seo, Young Eun, et al.
Publicado: (2014)

Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial
por: Tawfik, Ahmed M., et al.
Publicado: (2022)

Efficacy and Safety of Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: A 2-Year Follow-Up
por: Kim, Soodong, et al.
Publicado: (2018)

Correction to: Tadalafil monotherapy in management of chronic prostatitis/chronic pelvic pain syndrome: a randomized double-blind placebo controlled clinical trial
por: Tawfik, Ahmed M., et al.
Publicado: (2022)

Erratum: Acknowledgments. The Efficacy and Safety of Tadalafil 5 mg Once Daily in the Treatment of Erectile Dysfunction After Robot-Assisted Laparoscopic Radical Prostatectomy: 1-Year Follow-up
por: Seo, Young Eun, et al.
Publicado: (2014)

Boswellia resin extract and propolis derived polyphenols in patients with type III chronic prostatitis/chronic pelvic pain syndrome: An Italian prospective multicenter study
por: Presicce, Fabrizio, et al.
Publicado: (2022)

Efficacy and safety of low-intensity shockwave therapy plus tadalafil 5 mg once daily in men with type 2 diabetes mellitus and erectile dysfunction: a matched-pair comparison study
por: Verze, Paolo, et al.
Publicado: (2019)

Safety and Effectiveness of Once-Daily Tadalafil (5 mg) Therapy in Korean Men with Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms in a Real-World Clinical Setting: Results from a Post-Marketing Surveillance Study
por: Won, Ji Eon, et al.
Publicado: (2018)

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis
por: Babu, P Ravindra, et al.
Publicado: (2017)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
por: Fleischmann, Roy, et al.
Publicado: (2008)

Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction
por: Jang, Se Won, et al.
Publicado: (2022)

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
por: Roehrborn, Claus G, et al.
Publicado: (2008)

Correction: Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction
por: Jang, Se Won, et al.
Publicado: (2022)

Comparison of once daily versus twice daily olmesartan in patients with chronic kidney disease
por: Sakai, Yukinao, et al.
Publicado: (2013)

Duloxetine 60 mg once daily in the treatment of milder major depressive disorder
por: Perahia, DGS, et al.
Publicado: (2006)

Chronic Prostatitis/Chronic Pain Pelvic Syndrome and Male Infertility
por: Graziani, Andrea, et al.
Publicado: (2023)

Effects of tadalafil once daily or on demand versus placebo on time to recovery of erectile function in patients after bilateral nerve-sparing radical prostatectomy
por: Moncada, Ignacio, et al.
Publicado: (2014)

Penile Calciphylaxis treated with daily Tadalafil: Case report
por: Moya, Carlos Castro, et al.
Publicado: (2019)

Chronic non-cancer pain: Focus on once-daily tramadol formulations
por: Coluzzi, Flaminia, et al.
Publicado: (2007)

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
por: Jones, Paul W, et al.
Publicado: (2011)

Once daily levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria
por: Nettis, E, et al.
Publicado: (2008)

The Daily Therapy With L-Arginine 2,500 mg and Tadalafil 5 mg in Combination and in Monotherapy for the Treatment of Erectile Dysfunction: A Prospective, Randomized Multicentre Study
por: Gallo, Luigi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_no74iv4b3gpo15npa592ce42b8